Methods
=======

We analyzed Replicates 1--5 of the Genetic Analysis Workshop 15 (GAW15) simulated data using both linkage and association methods. The analyses were performed without knowledge of the \'answers\', however we subsequently obtained the \'answers\' to inform our discussion. Using 1500 fully genotyped affected-sib-pair (ASP) families (parents and two children) in each replicate, we first tested for linkage across the genome using the Kong and Cox \[[@B1]\] exponential model allele-sharing test as implemented (in the form of a LOD score) in the program Merlin \[[@B2]\]. We then performed transmission/disequilibrium tests (TDT) \[[@B3]\] for association across the genome using the non-dense 9187 single-nucleotide polymorphism (SNP) set. Both affected sibs from a sibship were used, with non-independence between them accounted for by use of a robust \'information sandwich\' variance estimator.

Given the highly significant results obtained on chromosome 6, we attempted to fine-map this region using first the original non-dense SNP set, then the dense chromosome 6 SNP set, and finally the combined non-dense/dense SNP set. We used the stepwise conditional logistic regression (case/pseudocontrol) approach for family data proposed by Cordell and Clayton \[[@B4]\]. We investigated whether any of the most significant loci could individually account for all of the association, and performed forward, backward, and forward then backward stepwise regression (using a *p*-value of 10^-3^to enter/exit the model) with the subset of SNPs showing a TDT χ^2^\> 30. We repeated the regression analyses using logistic (rather than conditional logistic) regression in a case/control data set constructed by taking the first affected sib from each ASP together with the 2000 fully genotyped population controls provided.

In addition to fine-mapping, we also investigated the use of a new likelihood-based association analysis approach in this region \[[@B5]\] in which data from different family structures and unrelated controls are analyzed together. This approach is implemented in the program LAMP <http://www.sph.umich.edu/csg/abecasis/LAMP/> and can be used to analyze either the full sample of ASPs together with the unrelated controls, the ASPs alone, a single affected sibling drawn from each ASP, or a single affected sibling together with the unrelated controls. Finally, we also used a recently proposed Bayesian approach for case/control association analysis \[[@B6]\] implemented in the program Graphminer. Although not specifically designed for fine-mapping, in simulation studies this approach has been shown to provide good localization of an underlying disease-causing variant, in comparison to more standard methods \[[@B6]\].

Results
=======

In each replicate, regardless of whether microsatellite or non-dense SNP markers were used, the most significant region of linkage was found on chromosome 6, centered around the 50 cM location where the \'true\' DR and C loci reside. The Kong and Cox \[[@B1]\] LOD scores on chromosome 6 were consistently in range 70--90, whereas on other chromosomes, only weak evidence of linkage (LOD scores in the range 1--2, none of which was consistent between the five replicates) was found.

When using the non-dense SNPs, highly significant TDT \[[@B3]\] results were obtained in each replicate on chromosome 6 (see results for Replicate 1 in Figure [1](#F1){ref-type="fig"}), at SNPs 152--155 (all of which lie within 0.17 cM of \'true\' loci DR and C) and at SNP 162 (which lies 0.05 cM from \'true\' locus D). An even larger number of significant TDT results were found in this region when using the dense SNP set (Figure [2](#F2){ref-type="fig"}). The only other TDT results that were consistently significant (*p*\< 10^-4^) across all five replicates were at SNP 389 on chromosome 11 (*p*-values 3 × 10^-23^, 1 × 10^-18^, 2 × 10^-15^, 1 × 10^-23^, 2 × 10^-21^in Replicates 1--5, respectively), and at SNP 269 on chromosome 18 (*p*-values 1 × 10^-7^, 5 × 10^-5^, 1 × 10^-7^, 1 × 10^-7^, 4 × 10^-9^, respectively). It is interesting to note from the \'answers\' that the position of the chromosome 11 result corresponds to \'true\' locus F which has an indirect effect on disease susceptibility through IgM, while the position of the chromosome 18 result corresponds to \'true\' locus E.

![TDT results for non-dense SNPS on chromosome 6 (Replicate 1).](1753-6561-1-S1-S23-1){#F1}

![TDT results for dense SNPS on chromosome 6 (Replicate 1).](1753-6561-1-S1-S23-2){#F2}

Table [1](#T1){ref-type="table"} shows the results from applying a stepwise regression procedure \[[@B4]\] for SNPs in the DR/C locus region in Replicates 1--5. With the non-dense SNPs, a number of significant loci remain in the final model, whereas with the dense SNP or combined non-dense/dense SNP set, only two or three SNPs (usually 3437 and 3439, or 3437 and 153) remain after forward then backward stepwise regression. These SNPs lie within 0.02 cM of the \'true\' DR and C locus location (49.46 cM) and account for all the association at this location; however, once they were included in the model, some residual association (*p*= 4 × 10^-8^) was still seen at \'true\' locus D (at 54.6 cM, Figure [3](#F3){ref-type="fig"}). Table [2](#T2){ref-type="table"} column 2 shows the SNPs around locus D that remained significant once SNPs in the DR/C locus region were included in the model. Applying a forward and backward stepwise regression procedure with these SNPs and those in the DR/C region generated a final model that generally included the two SNPs in the DR/C region and one (either 3931 or 3933) from the locus D region (Table [2](#T2){ref-type="table"}, columns 3 and 4). In all except Replicate 2, no other SNPs across the chromosome showed significance once this combination of three SNPs was included in the model (Figure [4](#F4){ref-type="fig"}). Case/control logistic regression was found to give broadly similar results to the family-based regression analysis in terms of the magnitude and pattern of significance (data not shown).

![**Residual association after stepwise regression**. Results are shown after accounting for SNPs 3437 and 3439 (Replicate 1).](1753-6561-1-S1-S23-3){#F3}

![**Residual association after stepwise regression**. Results are shown after accounting for SNPS 3437, 3439 and 3931 (Replicate 1).](1753-6561-1-S1-S23-4){#F4}

###### 

Forward and backward stepwise results for DR/C region^a^

  Replicate   Non-dense SNPs   Dense SNPs   Non-dense + Dense SNPs combined                               
  ----------- ---------------- ------------ --------------------------------- ------ ------ ------ ------ ------
  1           153              152          3442                              3437   3437   3442   3437   3437
              154              153          3430                              3439   3439   154    3439   3439
              162              154          3439                                            3439          
              155              155          3437                                            3437          
              152              162                                                                        
  2           153              153          3442                              3437   3437   3442   3437   3437
              154              154          3430                              3439   3439   3437   3439   3439
              162              162          3437                                            3439          
              150                           3439                                                          
  3           153              134          3442                              3437   3437   3442   153    153
              154              153          3437                              3439   3439   154    3437   3437
              162              154          3439                                            153    3439   
              134              162                                                          3437          
              155                                                                                         
  4           153              138          3442                              3437   3437   153    153    153
              154              139          3440                              3439   3439   3437   3437   3437
              162              153          3439                                                          
                               154          3437                                                          
                               162                                                                        
  5           153              153          3439                              3437   3437   153    153    153
              154              154          3437                              3439   3439   3437   3437   3437
              162              155                                                                        
              155              162                                                                        

^a^The SNPs listed are those that remain in the final model. SNPs in the \'Forward\' columns are shown in the same order in which they are added to the model.

###### 

Results from forwards and backwards stepwise procedure when adding SNPs in locus D region to SNPs in DR/C region

  Replicate   SNPs included in model   SNPs remaining in model          
  ----------- ------------------------ ------------------------- ------ ------
  1           3437                     162                       3439   3437
              3439                     3931                      3437   3439
                                       3933                      3931   3931
                                       3934                             
  2           3437                     162                       3439   3437
              3439                     3931                      3437   3439
                                       3933                      3931   3931
                                       3934                      3933   3933
                                                                 3934   3934
  3           153                      162                       3439   153
              3437                     3931                      3437   3437
              3439                     3933                      3931   3931
                                       3934                             
  4           153                      162                       153    153
              3437                     3931                      3437   3437
                                       3933                      3931   3933
                                       3934                             
  5           153                      162                       153    153
              3437                     3931                      3437   3437
                                       3933                      3931   3933
                                       3934                             

The results from the likelihood-based approach implemented in LAMP confirmed the association in this region. Not surprisingly, the highest significance with LAMP (a LOD score \> 600) was found when using the maximum sample size (all ASPs together with all unrelated controls). Strong evidence for association was also found using the Bayesian approach implemented in Graphminer. Both the non-dense and the dense SNP sets (Figures [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}) provided strong evidence of association at one or more locations, but the results were quite sensitive to various Graphminer parameters, in particular the parameter λ, which represents the mean of the prior for the number of cliques (contiguous SNP sets) associated with disease. In the example distributed with the Graphminer program, λ = 10^-9^is suggested, but Verzilli et al. \[[@B6]\] used λ = 0.01. We investigated values of λ in the range 0.01--10^-300^. With larger λ values, localization of a single location was not achieved (Figure [5](#F5){ref-type="fig"}): the results mimic the single-locus results found with the TDT or logistic regression. With smaller λ values, a single location was achieved (Figure [6](#F6){ref-type="fig"}), but in some replicates this location did not always precisely correspond to the DR/C locus location (data not shown).

![Graphminer results with dense SNPs (Replicate 1, λ = 10^-9^).](1753-6561-1-S1-S23-5){#F5}

![Graphminer results with dense SNPs (Replicate 1, λ = 10^-200^).](1753-6561-1-S1-S23-6){#F6}

Discussion
==========

Not surprisingly, given the large sample size and strong simulated effects at the DR, C and D loci (mimicking known effects at HLA in diseases such as RA and type 1 diabetes), this chromosome 6 region was consistently significantly implicated in disease susceptibility via both linkage and association analysis. No other regions were consistently implicated by linkage analysis, but genome-wide association analysis detected SNPs associated with disease susceptibility at locations corresponding to \'true\' loci E and F on chromosomes 18 and 11, in all five simulation replicates examined.

Fine mapping of the chromosome 6 region using Graphminer \[[@B6]\] did not always localize the true functional variants, and the choice of program parameters to use was not obvious. However, stepwise regression with the dense/combined SNP set was generally able to identify two SNPs (either 3437 and 3439 or 153 and 3437) that together account for all the association at the DR/C location, with residual evidence for association at locus D that can be accounted for through addition of a single SNP (either 3931 or 3933) in the locus D region. Using the genotype data provided in the \'answers\', we determined that SNP 3437--3439 and 3437-153 haplotypes are in very high linkage disequilibrium (LD) with the causal DRB1-C haplotype, while SNPs 3931 and 3933 are in high LD with causal locus D. Therefore, it is not surprising that this combination of SNPs generally captured most of the observed association. Given the data available, statistically speaking, this is probably the limit of what can be achieved with regard to fine-mapping in this region. Investigation of other populations (with different LD patterns) might highlight the fact these identified SNPs merely tag the true causal effects. The next phase of a real study would most likely involve determination of all genetic variation in the region (e.g., through sequencing), followed by functional investigation of all potential causal variants identified.
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